MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
MEGIN Announces New Distributor Partnership with Aerobe in India 

MEGIN Announces New Distributor Partnership with Aerobe in India 

by Naomi Devlin | Mar 13, 2026 | MEGIN News

MEGIN announces New Distributor Partnership with Aerobe in India by MEGIN | March 13, 2026 | MEGIN news HELSINKI, FINLAND. March 13, 2026 – MEGIN, a global leader in functional neuroimaging and magnetoencephalography (MEG) solutions, is pleased to announce a new...
MYndspan Shows Impact of Sleep Quality on Brain Function Using MEG

MYndspan Shows Impact of Sleep Quality on Brain Function Using MEG

by Naomi Devlin | Jan 21, 2026 | MEGIN News

How MEG Transforms Brain Tumor Surgery at UF Health

How MEG Transforms Brain Tumor Surgery at UF Health

by Naomi Devlin | Jan 13, 2026 | MEGIN News

MYndspan and MEGIN Partner to Make MEG Brain Scans More Accessible

MYndspan and MEGIN Partner to Make MEG Brain Scans More Accessible

by MEGIN | Feb 27, 2025 | MEGIN News

MYndspan and MEGIN Partner to Make MEG Brain Scans More Accessible by MEGIN | February 27, 2025 | MEGIN news LONDON, UK. February 27th, 2025 –  MYndspan, a pioneer in consumer brain health technology, announced a new partnership today with MEGIN, the global leader in...
MEGIN’s MEG Maps™ to transform the field of neuroscience, a field that is still limited by the performance of conventional neuroimaging modalities to date

MEGIN’s MEG Maps™ to transform the field of neuroscience, a field that is still limited by the performance of conventional neuroimaging modalities to date

by MEGIN | Jul 1, 2024 | MEGIN News

MEGIN, a leader in functional neuroimaging technology, made a significant announcement today by unveiling MEG Maps™, a cutting-edge neuroimaging scanner platform. All the components of this platform have received FDA 510(k) clearance, marking a major step forward in...
Westcan Proton Therapy Inc. will establish Canada’s first proton therapy facility in Edmonton, Alberta in coordination with MEGIN and other industry leading partners

Westcan Proton Therapy Inc. will establish Canada’s first proton therapy facility in Edmonton, Alberta in coordination with MEGIN and other industry leading partners

by MEGIN | Mar 20, 2024 | MEGIN News

EDMONTON, AB – WestCan Proton Therapy Inc. has announced their plans to invest in Canada’s first proton therapy treatment centre to be built in Edmonton. The centre will officially be named in honour of Ben Stelter, beloved six-year-old Edmonton Oilers super-fan and...
« Older Entries
Next Entries »

Home
About us
MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.